Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Sale of 8,569 STIM shares, $11.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Neuronetics, Inc. (STIM) | Sale | 8,569 | $11.5K |
| Mar 18, 2026 | Neuronetics, Inc. (STIM) | Grant/Award | 25,000 | n/a |
| Feb 25, 2026 | Neuronetics, Inc. (STIM) | Grant/Award | 250,000 | n/a |
| Dec 31, 2025 | Neuronetics, Inc. (STIM) | Grant/Award | 170,212 | n/a |
| Jul 15, 2025 | Neuronetics, Inc. (STIM) | Grant/Award | 200,000 | n/a |
| Aug 7, 2024 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale | 4,657 | $5.3K |
| Jun 20, 2024 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/Award | 12,733 | n/a |
| Feb 21, 2024 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Sale | 3,092 | $30.8K |
| Jan 19, 2024 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/Award | 25,465 | n/a |